Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 01/26/24 07:30:00 on US and Canada Markets.
Canopy Growth to Report Third Quarter Fiscal 2024 Financial Results on February 9, 2024 Canada NewsWire SMITHS FALLS, ON , Jan. 26, 2024 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial resu...
W. P. Carey to Release Fourth Quarter and Full Year 2023 Financial Results on Friday, February 9, 2024 PR Newswire Conference Call Scheduled for 10:00 a.m. Eastern Time NEW YORK , Jan. 26, 2024 /PRNewswire/ -- W. P. Carey Inc. (W. P. Carey, NYSE: WPC)...
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / January 26, 2024 / South Star Battery Metals Corp. (" South Star " or the " Company ") (TSXV: STS ) (OTCQB: STSBF ), is pleased to announce that as a ...
BOSTON, Jan. 26, 2024 (GLOBE NEWSWIRE) -- DraftKings Inc. (Nasdaq: DKNG) (the “Company” or “DraftKings”) today announced that it will release its fourth quarter and full year 2023 results after the close of market trading on Thursday, February 15, 2024. DraftKing...
Q3W schedule of CRB-701 (SYS6002) demonstrates a 43% ORR and 71% DCR at predicted therapeutically relevant doses All assessable nectin-4 positive study participants with mUC and cervical cancer treated at or above this dose demonstrated some level of disease control No dose limiting tox...
2024-01-26 07:25:15 ET A double-digit jump in share price is typically what doesn't happen when a company reports earnings featuring declines in key metrics, not to mention a double miss on both revenue and profitability. Yet after Nokia (NYSE: NOK) published its latest quar...
Recommendation for approval based on Phase 3 KarMMa-3 study in which Abecma demonstrated superiority over standard regimens, significantly improved progression-free survival and a well-established safety profile with mostly low-grade occurrences of cytokine release syndrome and neurotoxicity ...
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the following management changes. Interim CFO Appointment and Transition The Company will appoint Ms. Katie Martinovich as Interim Chief Financia...
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the following management changes. Interim CFO Appointment and Transition The Company will appoint Ms. Katie Martinovich as Interim Chief Financia...
WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a negative opinion on the marketing authorization application (MAA) of intravi...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-9.35%Change Percent:
Novo Integrated Sciences Inc. Company Name:
NVOS Stock Symbol:
OTCMKTS Market:
novointegrated.com Website: